Copyright
©The Author(s) 2022.
World J Gastroenterol. Sep 14, 2022; 28(34): 5076-5085
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.5076
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.5076
Table 1 Characteristics of 16 transplanted patients with gastrointestinal stromal tumors
Overall number | ||
Male sex, n (%) | 16 | 11 (69) |
Age (yr), median (min; max) | 16 | 59.5 (23; 74) |
Type of organ transplantation, n (%) | 16 | |
Kidney | 12 (75) | |
Liver | 4 (25) | |
Location of primitive tumor, n (%) | 16 | |
Stomach | 9 (56) | |
Small bowel | 3 (19) | |
Colon | 1 (6) | |
Other: pelvis, perineum, mesentery | 3 (19) | |
Time from transplantation to diagnosis (mo), median (min; max) | 16 | 32 (5; 252) |
Metastatic dissemination at diagnosis, n (%) | 16 | 0 (0) |
Tumor size (mm), median (min; max) | 15 | 45 (10; 230) |
Risk of progression according to Joensuu’s criteria, n (%) | 14 | |
Very low | 2 (14) | |
Low | 4 (29) | |
Intermediate | 2 (14) | |
High | 6 (43) | |
Surgical treatment, n (%) | 16 | 15 (94) |
Adjuvant treatment, n (%) | 16 | 3 (19) |
Modification of immunosuppression, n (%) | 11 | 9 (82) |
Death during follow-up, n (%) | 14 | 4 (29) |
- Citation: Stammler R, Anglicheau D, Landi B, Meatchi T, Ragot E, Thervet E, Lazareth H. Gastrointestinal tumors in transplantation: Two case reports and review of literature . World J Gastroenterol 2022; 28(34): 5076-5085
- URL: https://www.wjgnet.com/1007-9327/full/v28/i34/5076.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i34.5076